In vitro diagno substances, reagents

Ended Awarded Last action

Contract number
HHSN261201000012I
Awardee
Awarding agency
Task orders
1 $178,230 obligated

Award facts

Combined order value
$178,230 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 81% used
$219,360.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The $178,230 firm fixed-price delivery order is for the recovery and delivery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program, which is part of the agency's efforts to characterize the genomic changes in cancer. Sloan-Kettering Institute for Cancer Research is a subcontractor to the overall TCGA program, which is managed by the prime contractor, Memorial Sloan Kettering Cancer Center, another non-profit research institution. This delivery order falls under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery, indefinite quantity (IDIQ) contract, which has no set-aside designation. The contract has a period of performance through March 2015 and is funded through the American Recovery and Reinvestment Act (ARRA).

The primary purpose of this contract is to support the TCGA program by providing cancer tissue samples and associated data to aid in the genomic characterization of various cancer types. As a subcontractor, Sloan-Kettering Institute for Cancer Research will leverage its expertise in cancer research and biospecimen management to recover and deliver the required samples and data to the NCI. This work contributes to the broader goals of the TCGA program, which seeks to improve the understanding of the molecular basis of cancer and accelerate the development of more effective cancer diagnostics and treatments.

Task orders

Transactions

Action Obligated Date
Other Administrative Action 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $0

Quick answers

Who was awarded contract HHSN261201000012I?

HHSN261201000012I was awarded to Sloan-Kettering Institute For Cancer Research by National Cancer Institute (National Institutes of Health) on March 1, 2010.

How much is contract HHSN261201000012I worth?

Orders under HHSN261201000012I have obligated $178,230. HHSN261201000012I's own ceiling is $219,360.

How many orders have been placed under contract HHSN261201000012I?

1 order has been placed under HHSN261201000012I, the latest on March 15, 2010.

Who can order from contract HHSN261201000012I?

HHSN261201000012I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201000012I part of a contract vehicle?

Yes. HHSN261201000012I is part of NCI Cancer Genome Atlas Program Tissue Purchase.

Was contract HHSN261201000012I competed?

The extent of competition for HHSN261201000012I was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV